Top

Reactions Weekly

Published in:

01-06-2023 | Basalioma | Case report

Vismodegib

Various toxicities: 5 case reports

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Ayen-Rodriguez A, et al. Retrospective Real-Life Data, Efficacy and Safety of Vismodegib Treatment in Patients with Advanced and Multiple Basal Cell Carcinoma: 3-Year Experience from a Spanish Center. International Journal of Environmental Research and Public Health 20: no pagination, No. 10, Jan 2023. Available from: URL: http://doi.org/10.3390/ijerph20105824

Title: Vismodegib
Various toxicities: 5 case reports
Publication date: 01-06-2023
Publisher: Springer International Publishing
Keywords: Basalioma
Basalioma
Basalioma
Alopecia
Dyslipidemia
Basalioma
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-42052-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Vismodegib

Various toxicities: 5 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Tacrolimus

Methylprednisolone

Gentamicin/moxifloxacin

Osimertinib/sitagliptin

Infliximab

Magnesium-sulfate/potassium-sulfate/simethicone/sodium-sulfate